Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03536221 · ClinicalTrials.gov registry record
What is the Prevalence of Female Pelvic Floor Disorders in Minnesota?
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 1,200
- Enrollment target
NCT03536221: Completed study, sponsored by University of Minnesota.
NCT03536221 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03536221 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
To determine the prevalence of pelvic organ prolapse and urinary incontinence among women in Minnesota using a short web-based self-administered questionnaire.
Primary Outcome
Prevalence of prolapse in the population studied
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-09-30 |
What the finished NCT03536221 record still lists
NCT03536221 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03536221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03536221 about?
NCT03536221 is a clinical study titled "What is the Prevalence of Female Pelvic Floor Disorders in Minnesota?". To determine the prevalence of pelvic organ prolapse and urinary incontinence among women in Minnesota using a short web-based self-administered questionnaire.
What is the current status of trial NCT03536221?
This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2018-08-01. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT03536221?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI